Streetbeat News

GCTK

GlucoTrack, Inc.

https://www.glucotrack.com

Industry

Medical - Instruments & Supplies

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Open

0.26

Mkt cap

1.4M

Volume

474K

High

0.26

P/E Ratio

-0.09

52-wk high

4.95

Low

0.22

Div yield

N/A

52-wk low

0.22

Health care stocks showed significant movement in Tuesday's intraday session with notable gainers and losers following their Q1 earnings reports. Nuwellis, Bioventus, and Design Therapeutics were among the top gainers, while Neuronetics, Helius Medical Technologies, and Allarity Therapeutics led the losses.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 4:31 pm

In Tuesday's pre-market session, health care stocks showed significant movement. Cyclacel Pharmaceuticals, GeneDx Hldgs, BioRestorative Therapies, Vaccinex, Addex Therapeutics, and Tenet Healthcare were among the gainers, with notable increases in their stock prices. On the other hand, SHL Telemedicine, Nektar Therapeutics, GlucoTrack, GE HealthCare Techs, Virios Therapeutics, and 180 Life Sciences experienced declines. The movements were influenced by factors such as Q1 earnings reports for some companies.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 12:06 pm

In Monday's after-market session, several health care stocks showed notable movements. GeneDx Holdings led the gainers with a 21.8% increase following their Q1 earnings release, while GlucoTrack experienced the largest decline among the losers, dropping 10.7%. Other notable movers included InnovAge Holding, Mustang Bio, and Vaxxinity, each responding to market dynamics and company-specific news.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 8:31 pm

Insiders at Tecogen Inc., Bespoke Extracts Inc., and GlucoTrack Inc. have recently made significant purchases of their companies' stocks, signaling potential confidence in their respective companies' futures. Tecogen is poised to release its Q1 financial results, Bespoke Extracts has seen a 22% stock decline over six months, and GlucoTrack announced the closing of a private placement.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:03 pm

Teledyne Technologies shares fell by 9% after reporting disappointing Q1 financial results and cutting FY24 EPS guidance. Other stocks showed significant movement, with notable gainers including Chicken Soup for the Soul Entertainment and BranchOut Food, and losers like Neo-Concept International and iSun.

Portfolio Pulse from Avi Kapoor

April 24, 2024 | 5:57 pm

Health care stocks showed significant movement in Wednesday's intraday session, with notable gainers including Catheter Precision, Prenetics Global, and Alterity Therapeutics, among others. On the downside, GlucoTrack, Evotec, and Vaxxinity led the losers, with Evotec and Addex Therapeutics specifically reacting to their Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 4:31 pm

Nasdaq rose 0.5% with Tesla shares jumping 10% after Q1 results, despite missing earnings and sales expectations. BranchOut Food, Amesite, and Chicken Soup for the Soul Entertainment saw significant gains, while Evotec, Avenue Therapeutics, and GlucoTrack experienced sharp declines. The article also highlights sector movements, with consumer discretionary shares up and industrials down.

Portfolio Pulse from Avi Kapoor

April 24, 2024 | 2:30 pm

In Monday's intraday session, several healthcare stocks experienced significant movements. NKGen Biotech led the gainers with a 33.8% increase, while Vaxxinity saw the largest decline among the losers, dropping 52.9%. Other notable movers included MSP Recovery, Assure Holdings, ProKidney, iSpecimen, GlucoTrack, Hepion Pharmaceuticals, Bio-Path Holdings, Inhibikase Therapeutics, Telomir Pharmaceuticals, and Ocean Biomedical. Market capitalizations varied widely among these companies, reflecting diverse investor reactions to recent earnings reports and market dynamics.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 4:31 pm

In Monday's pre-market session, several healthcare stocks showed significant movement. Longeveron (LGVN) led the gainers with a 75.0% increase, while BioRestorative Therapies (BRTX) experienced the largest drop among the losers, falling 18.8%. Other notable movers include PetVivo Holdings (PETV) and Ocugen (OCGN), which saw increases of 17.09% and 8.19%, respectively. On the downside, Supernus Pharmaceuticals (SUPN) and Virpax Pharmaceuticals (VRPX) saw declines of 16.34% and 11.32%, respectively.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 12:09 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Candel Therapeutics, Galectin Therapeutics, and Ocugen were among the top gainers, with notable increases in their stock prices. Conversely, Acorda Therapeutics, Aesthetic Medical Intl, and Ontrak were among the top losers, experiencing significant declines. The movements were attributed to various factors, including quarterly earnings releases for some companies.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 4:39 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.